Robust optogenetic inhibition with red-light-sensitive anion-conducting channelrhodopsins.

anion-conducting channelrhodopsins channelrhodopsins low light sensitivity metagenomics mouse neuroscience red-light optogenetics

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
14 Oct 2024
Historique:
medline: 14 10 2024
pubmed: 14 10 2024
entrez: 14 10 2024
Statut: epublish

Résumé

Channelrhodopsins (ChRs) are light-gated ion channels widely used to optically activate or silence selected electrogenic cells, such as individual brain neurons. Here, we describe identifying and characterizing a set of anion-conducting ChRs (ACRs) from diverse taxa and representing various branches of the ChR phylogenetic tree. The

Identifiants

pubmed: 39401075
doi: 10.7554/eLife.90100
pii: 90100
doi:
pii:

Substances chimiques

Channelrhodopsins 0
Anions 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SFB 1078 B2 221545957
Organisme : Israel Science Foundation
ID : 3131/20
Organisme : Alexander von Humboldt-Stiftung
ID : 99999.001756/2014-01
Organisme : EU Joint Programme - Neurodegenerative Disease Research
ID : JPco-FuND - NiPARK
Organisme : Leibniz-Gemeinschaft
ID : Program 'BestMinds' MP J28/2017 SheLi
Organisme : Aligning Science Across Parkinson's
ID : ASAP-020505

Informations de copyright

© 2023, Oppermann et al.

Déclaration de conflit d'intérêts

JO, AR, TF, CG, RP, OB, MP, PH No competing interests declared

Auteurs

Johannes Oppermann (J)

Institut für Biologie, Experimentelle Biophysik, Humboldt-Universität zu Berlin, Berlin, Germany.

Andrey Rozenberg (A)

Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel.

Thomaz Fabrin (T)

Research Group Neuromodulatory Networks, Leibniz Institute for Neurobiology, Magdeburg, Germany.

Cristian González-Cabrera (C)

Research Group Neuromodulatory Networks, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.

Rafael Parker (R)

Research Group Neuromodulatory Networks, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.

Oded Béjà (O)

Faculty of Biology, Technion - Israel Institute of Technology, Haifa, Israel.

Matthias Prigge (M)

Research Group Neuromodulatory Networks, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, United States.
Center for Behavioral Brain Sciences, CBBS, Magdeburg, Germany.

Peter Hegemann (P)

Institut für Biologie, Experimentelle Biophysik, Humboldt-Universität zu Berlin, Berlin, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH